In the TAC group, the urinary protein levels decreased from 6.3 ± 3.4 g/day at baseline to 3.4 ± 2.8 g/day at week 12 (p < 0.05), 1.9 ± 1.6 g/day at week 24 (p < 0.05), and 2.1 ± 1.9 g/day at week 36 (p < 0.05), whereas serum albumin levels significantly increased from 23.5 ± 7.4 g/l at baseline to 38.4 ± 7.9 g/l at week 12, 40.7 ± 6.7 g/l at week 24, and 41.4 ± 8.1 g/l at week 36 (p < 0.05). The gene discussed is ALB; the disease is persistent truncus arteriosus.